Kala Pharmaceuticals Stock Analysis

Kala Stock Analysis Notes

About 64.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 7.36. Kala Pharmaceuticals had not issued any dividends in recent years. The entity had 1:50 split on the 21st of October 2022. Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. Kala Pharmaceuticals, Inc. was incorporated in 2009 and is headquartered in Watertown, Massachusetts. Kala Pharmaceuticals operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 192 people. To find out more about Kala Pharmaceuticals contact Mark Iwicki at 781 996 5252 or learn more at https://www.kalarx.com.

Kala Pharmaceuticals Investment Alerts

Kala Pharmaceuticals Upcoming and Recent Events

Kala Largest EPS Surprises

View All Earnings Estimates

Kala Pharmaceuticals Environmental, Social, and Governance (ESG) Scores

Kala Stock Institutional Investors

Note, although Kala Pharmaceuticals' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Kala Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 35.49 M.

Kala Profitablity

Management Efficiency

Kala Pharmaceuticals has return on total asset (ROA) of (0.4851) % which means that it has lost $0.4851 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.7646) %, meaning that it created substantial loss on money invested by shareholders. Kala Pharmaceuticals' management efficiency ratios could be used to measure how well Kala Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of July 23, 2025, Return On Tangible Assets is expected to decline to -0.73. In addition to that, Return On Capital Employed is expected to decline to -1.12. At present, Kala Pharmaceuticals' Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 2.4 M, whereas Non Current Assets Total are forecasted to decline to about 2.6 M.

Technical Drivers

As of the 23rd of July, Kala Pharmaceuticals secures the Risk Adjusted Performance of 0.1264, mean deviation of 5.26, and Downside Deviation of 5.27. Kala Pharmaceuticals technical analysis lets you operate historical price patterns with an objective to determine a pattern that forecasts the direction of the firm's future prices.

Kala Pharmaceuticals Price Movement Analysis

Kala Pharmaceuticals Insider Trading Activities

Kala Pharmaceuticals Outstanding Bonds

Kala Pharmaceuticals Predictive Daily Indicators

Kala Pharmaceuticals Corporate Filings

Kala Pharmaceuticals Forecast Models

Kala Pharmaceuticals' time-series forecasting models are one of many Kala Pharmaceuticals' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Kala Pharmaceuticals' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Kala Pharmaceuticals prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Kala shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Kala Pharmaceuticals. By using and applying Kala Stock analysis, traders can create a robust methodology for identifying Kala entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Kala analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Kala analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Kala Pharmaceuticals stock analysis indicators help investors evaluate how Kala Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Kala Pharmaceuticals shares will generate the highest return on investment. By understating and applying Kala Pharmaceuticals stock analysis, traders can identify Kala Pharmaceuticals position entry and exit signals to maximize returns.

When running Kala Pharmaceuticals' price analysis, check to measure Kala Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kala Pharmaceuticals is operating at the current time. Most of Kala Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Kala Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kala Pharmaceuticals' price. Additionally, you may evaluate how the addition of Kala Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.